Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
20.84
+1.53 (7.92%)
At close: Aug 4, 2026, 4:00 PM EDT
20.44
-0.40 (-1.92%)
After-hours: Aug 4, 2026, 7:34 PM EDT
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $2.3 billion as of August 4, 2026. Its market cap has increased by 62.01% in one year.
Market Cap
2.30B
Enterprise Value
1.59B
1-Year Change
62.01%
Ranking
Category
Stock Price
$20.84
ChartMarket Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $2.30B, an increase of 6,532.03%. That is a compound annual growth rate of 41.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 1.99B | -32.99% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.25B |
| Kailera Therapeutics | 2.24B |
| Sionna Therapeutics | 2.22B |
| SELLAS Life Sciences Group | 2.21B |
| Nuvation Bio | 2.14B |
| Hemab Therapeutics Holdings | 2.10B |
| Harmony Biosciences Holdings | 2.06B |
| Zai Lab | 2.04B |